EOLS

Evolus Inc

EOLS, USA

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

https://www.evolus.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
EOLS
stock
EOLS

2,435,550 Shares in Evolus, Inc. $EOLS Bought by Frazier Life Sciences Management L.P. MarketBeat

Read more →
EOLS
stock
EOLS

Frontier Capital Management Co. LLC Buys 457,533 Shares of Evolus, Inc. $EOLS Defense World

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$18.6667

Analyst Picks

Strong Buy

4

Buy

3

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

-15.84

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very High

54.72 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-7.19 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-24.40 %

Low ≤ 5%

High ≥ 15%

Investors

* Institutions hold a combined 24.47% of the total shares of Evolus Inc

1.

BioPharma Credit Ord

(8.7519%)

since

2024/12/31

2.

Vanguard Total Stock Mkt Idx Inv

(2.6099%)

since

2025/07/31

3.

iShares Russell 2000 ETF

(1.9893%)

since

2025/08/31

4.

Schroder US Smaller Companies Acc

(1.1825%)

since

2025/07/31

5.

Oberweis Micro-Cap Growth

(1.0475%)

since

2025/06/30

6.

Oberweis Micro-Cap

(1.0475%)

since

2025/06/30

7.

Vanguard Institutional Extnd Mkt Idx Tr

(0.8422%)

since

2025/07/31

8.

Fidelity Small Cap Index

(0.8275%)

since

2025/06/30

9.

Invesco S&P 500 ETF

(0.7246%)

since

2025/07/31

10.

iShares Russell 2000 Growth ETF

(0.7192%)

since

2025/08/31

11.

Nuveen Quant Small Cap Equity R6

(0.7062%)

since

2025/07/31

12.

Frontier Small Cap Growth

(0.6639%)

since

2025/06/30

13.

CREF Stock R3

(0.5132%)

since

2025/07/31

14.

Altium Capital Management, LP

(0.4579%)

since

2025/03/31

15.

Fidelity Extended Market Index

(0.4213%)

since

2025/07/31

16.

Vanguard Russell 2000 ETF

(0.3945%)

since

2025/07/31

17.

JPMorgan US Small Company L

(0.387%)

since

2025/07/31

18.

Schwab US Small-Cap ETFâ„¢

(0.363%)

since

2025/08/30

19.

State St Russell Sm Cap® Indx SL Cl I

(0.3068%)

since

2025/08/31

20.

SPDR® S&P Pharmaceuticals ETF

(0.2596%)

since

2025/08/31

21.

Schroder U.S. Small Cap Core

(0.2562%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.1478

EPS Estimate

-0.1467

EPS Difference

-0.0011

Surprise Percent

-0.7498%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(0.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(5.8)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(2.5)
Momentum
Moderate Momentum(4)
Net Net
Not Undervalued (Net-Net)(0.5)
Quality
Low Quality Business(2.5)
Value
Overpriced(2.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.